Other Hallucinogen Use Disorder is a substance use disorder characterized by a problematic pattern of hallucinogen use (not phencyclidine or phencyclidine-like substances) use leading to clinically significant impairment or distress. Of the other hallucinogens, MDMA is thought to have the greatest risk in terms of withdrawal symptoms and neurological impairment.
A problematic pattern of hallucinogen (other than phencyclidine) use leading to clinically significant impairment or distress, as manifested by at least 2
of the following, occurring within a 12
-month period:
Specify if:
3
months but for less than 12
months (with the exception that Criterion A4
, “Craving, or a strong desire or urge to use the hallucinogen,” may be met).12
months or longer (with the exception that Criterion A4
, “Craving, or a strong desire or urge to use the hallucinogen,“ may be met).Specify if:
Specify if:
2
to 3
symptoms4
to 5
symptoms6
+ symptoms